Graham R. .v. Hughes

Graham R. .v. Hughes's AcademicInfluence.com Rankings

Medical

#648

World Rank

#866

Historical Rank

Rheumatology

World Rank

Historical Rank

medical Degrees

Graham R. .v. Hughes

Philosophy

#2603

World Rank

#4396

Historical Rank

Logic

#667

World Rank

#1164

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Graham R. .v. Hughes Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Graham R. .v. Hughes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. (1999) (2685)
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. (2002) (1813)
Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients (2003) (1214)
Systemic Vasculitis with Asthma and Eosinophilia: A Clinical Approach to the Churg‐Strauss Syndrome (1984) (1137)
The management of thrombosis in the antiphospholipid-antibody syndrome. (1995) (1073)
The anticardiolipin syndrome. (1985) (1069)
The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features (1989) (998)
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. (1983) (917)
Systemic Lupus Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1,000 Patients (1993) (909)
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. (1987) (740)
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. (1987) (679)
The antiphospholipid syndrome: ten years on (1993) (660)
Systemic lupus erythematosus (2001) (578)
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. (1986) (569)
Systemic lupus erythematosus (2016) (527)
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. (1983) (513)
Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. (2003) (457)
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. (1983) (419)
Antiphospholipid antibodies (1994) (382)
Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. (1996) (352)
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. (1989) (328)
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients (2008) (306)
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody (1985) (289)
The Role of the Tissue Factor Pathway in the Hypercoagulable State in Patients with the Antiphospholipid Syndrome (1998) (285)
Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. (1988) (236)
Connective Tissue Diseases (1977) (234)
Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. (1990) (227)
Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. (1997) (226)
Anti-phospholipid antibodies. (1985) (223)
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. (1984) (220)
Systemic lupus erythematosus. A prospective analysis. (1978) (219)
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis (2003) (215)
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients (1998) (214)
Oxidation of LDL and its clinical implication. (2008) (213)
Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody (1984) (206)
Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus (2004) (196)
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. (1984) (196)
Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. (1996) (192)
Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. (2003) (192)
Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. (1979) (192)
Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. (1995) (187)
Serological markers in progressive systemic sclerosis: clinical correlations. (1983) (183)
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. (1999) (175)
Seronegative antiphospholipid syndrome (2003) (172)
Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. (1994) (166)
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. (2010) (166)
Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. (1980) (163)
Diaphragm function and lung involvement in systemic lupus erythematosus. (1977) (162)
Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. (1987) (162)
Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. (2002) (157)
Central nervous system involvement in the antiphospholipid (Hughes) syndrome. (2003) (155)
Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. (1989) (154)
Fetal loss in systemic lupus: association with anticardiolipin antibodies (1985) (153)
Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. (1996) (152)
beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. (1994) (150)
Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies. (1987) (148)
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. (2002) (146)
Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. (2004) (145)
Anticardiolipin antibodies: occurrence in Behçet's syndrome. (1984) (141)
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". (2006) (139)
European consensus statement on the terminology used in the management of lupus glomerulonephritis (2009) (137)
Crossreactivity of antiphospholipid antibodies. (1985) (136)
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. (1973) (135)
Systemic lupus erythematosus flares during pregnancy. (1997) (135)
Long-Term Follow-Up in 128 Patients With Primary Antiphospholipid Syndrome: Do They Develop Lupus? (2005) (133)
Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. (1993) (132)
Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? (2005) (130)
Thrombocytopenia in the antiphospholipid syndrome (1997) (128)
Obstetric outcome in systemic lupus erythematosus. (1995) (128)
Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. (1998) (128)
Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. (1985) (128)
High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome (1991) (127)
Antiphospholipid Anti-Bodies—Autoantibodies with a Difference (1988) (127)
Histiocytic necrotizing lymphadenitis, Kikuchi-Fujimoto's disease, associated with systemic lupus erythemotosus. (1997) (124)
Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. (1988) (123)
Migraine, memory loss, and “multiple sclerosis ”. Neurological features of the antiphospholipid (Hughes’) syndrome (2003) (123)
Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide (1997) (122)
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. (1971) (122)
Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis (1991) (121)
Features associated with epilepsy in the antiphospholipid syndrome. (2004) (121)
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. (2004) (119)
Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. (1998) (119)
Systemic vasculitis with asthma and eosinophilia (1984) (118)
Anticentromere antibody in primary biliary cirrhosis. (1982) (116)
Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. (1984) (115)
Calprotectin in Patients with Systemic Lupus Erythematosus: Relation to Clinical and Laboratory Parameters of Disease Activity (1993) (113)
High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. (2007) (112)
Immunosuppressive therapy in lupus nephritis. (1997) (111)
Antiprothrombin antibodies detected in two different assay systems (2005) (110)
Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. (2002) (110)
Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. (1997) (109)
Antibodies to endothelial cells in patients with Behçet's disease. (1993) (109)
Antiphospholipid antibodies and antiphospholipid syndrome (1995) (109)
Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease. (1982) (108)
Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients. (2005) (107)
Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension (2003) (107)
SLE retinopathy: evaluation by fluorescein angiography. (1982) (106)
Pulmonary hypertension in systemic lupus erythematosus. (1983) (100)
Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. (1979) (99)
Pregnancy in systemic lupus erythematosus. (1996) (99)
Systemic Endothelial Cell Markers in Primary Antiphospholipid Syndrome (2000) (98)
The central nervous system in systemic lupus erythematosus (2004) (98)
Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. (1998) (98)
Antiphospholipid syndrome: five year follow up. (1991) (97)
Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature (1995) (96)
Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. (1996) (94)
Affinity purified anti-cardiolipin and anti-DNA antibodies. (1985) (93)
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. (2010) (92)
Degos' disease: association with anticardiolipin antibodies and the lupus anticoagulant. (1984) (89)
Major histocompatibility complex associations with primary antiphospholipid syndrome. (1992) (88)
Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. (1998) (87)
Significance of persisting serologic abnormalities in SLE. (1976) (87)
An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. (1979) (87)
Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. (1988) (86)
Mycophenolate mofetil treatment in resistant myositis. (2007) (86)
Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. (1989) (85)
Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases. (1986) (85)
Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK (2001) (84)
Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. (1989) (82)
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. (2004) (81)
Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. (1998) (80)
A chimeric antibody with the human γ1 constant region as a putative standard for assays to detect IgG β2‐glycoprotein I–dependent anticardiolipin and anti–β2‐glycoprotein I antibodies (1999) (80)
The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms. (1979) (79)
Cellular protein and RNA antigens in autoimmune disease. (1984) (78)
Hughes Syndrome: The Antiphospholipid Syndrome (1998) (78)
Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. (1977) (77)
Nuclear Magnetic Resonance (NMR) Imaging of the Brain in Systemic Lupus Erythematosus (1983) (77)
Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. (1995) (77)
Release of calreticulin from neutrophils may alter C1q-mediated immune functions. (1997) (76)
High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus. (1987) (76)
Sjögren's syndrome and autoimmunity in a geriatric population. (1972) (75)
Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens. (2005) (75)
HLA antigen frequencies in systemic vasculitis: increase in HLA-DR2 in Wegener's granulomatosis. (1983) (75)
Systemic lupus erythematosus in childhood. (1981) (75)
Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus (1992) (75)
The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. (1997) (75)
Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. (2004) (75)
Antiphospholipid antibody tests: spreading the net (2005) (74)
Systemic lupus erythematosus. (1977) (73)
Antiphospholipid antibodies in cerebral ischemia. (1991) (73)
The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. (2001) (73)
Assessment of platelet function in patients with Raynaud's syndrome. (1984) (72)
Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. (1997) (72)
Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. (1982) (71)
Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. (1991) (71)
Epilepsy: an early symptom of systemic lupus erythematosus. (1985) (70)
Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome. (1989) (70)
THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS (1973) (69)
Anticardiolipin antibodies in Lyme disease. (1988) (69)
Hypoadrenalism, Addison's disease and antiphospholipid antibodies. (1991) (68)
The use of hydroxychloroquine in lupus pregnancy: the British experience. (1996) (68)
Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies. (1985) (68)
Hughes’ syndrome: The antiphospholipid syndrome. A historical view (1998) (68)
Hughes Syndrome (the antiphospholipid syndrome): ten clinical lessons. (2008) (67)
Migraine and stroke in young women. (2000) (66)
C-reactive protein levels in systemic lupus erythematosus: a classification criterion? (1980) (66)
Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment. (1990) (65)
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis (2005) (65)
Rheumatoid arthritis and food: a case study. (1981) (65)
Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease (2005) (65)
Low dose methotrexate treatment in adult Still's disease. (1992) (65)
The release of DNA into serum and synovial fluid. (1971) (65)
Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. (1996) (64)
Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome (2003) (64)
Plasma Tumor Necrosis Factor α Levels and the –238* A Promoter Polymorphism in Patients with Antiphospholipid Syndrome (2001) (64)
A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. (1991) (64)
IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis. (1983) (63)
Correlation between β2-glycoprotein I valine/leucine247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome (1999) (62)
IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus. (1988) (62)
Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. (1971) (62)
A Study of 100 High Risk Lupus Pregnancies (1992) (61)
Pulmonary hypertension in systemic lupus erythematosus: a report of three cases. (1986) (61)
Hypertension, renal artery stenosis and the "primary" antiphospholipid syndrome. (1991) (59)
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study (2003) (57)
Antiphospholipid antibodies--autoantibodies with a difference. (1988) (55)
Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil. (2005) (55)
Systemic lupus erythematosus: two patients treated with danazol (1982) (55)
Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. (1998) (55)
Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data (2004) (55)
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome (2002) (54)
Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. (1982) (54)
Hughes Syndrome, the Antiphospholipid Syndrome: A New Chapter in Neurology (2005) (53)
Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks. (1988) (53)
Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities. (1987) (53)
Cerebral systemic lupus erythematosus presenting with catatonia. (1985) (53)
ACP Broadsheet no 136: February 1993. Detection and importance of anticardiolipin antibodies. (1993) (53)
Quantitative scintigraphy in diagnosis and management of plantar fasciitis (calcaneal periostitis): concise communication. (1980) (52)
Thrombosis and Antiphospholipid Syndrome: a Preliminary Assessment of Three Antithrombotic Treatments (1994) (52)
Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations, and treatment. (1991) (51)
HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. (2001) (51)
Neuropsychiatric problems in systemic lupus erythematosus. (1972) (51)
Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. (1999) (51)
Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis. (1992) (51)
Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis. (1985) (51)
Allergic Disorders in Systemic Lupus Erythematosus (1993) (50)
Significance of eosinophilia during gold therapy. (1974) (50)
Bilateral adrenal infarction, hypoadrenalism and splinter haemorrhages in the 'primary' antiphospholipid syndrome. (1992) (50)
Immunological Studies on the Mechanism of Gold Hypersensitivity Reactions (1973) (50)
Value of Immunologic Testing in Stroke Patients: A Prospective Multicenter Study (1994) (50)
Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease. (1991) (49)
Deficiency of factor B of the complement system in sickle cell anaemia. (1976) (48)
A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. (1999) (48)
Phospholipid-Binding Antibodies (1991) (47)
Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by Bruneau et al. (1988) (47)
Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis. (1992) (47)
Pregnancy in granulomatous vasculitis. (1995) (47)
Cerebral disease in systemic lupus erythematosus (2004) (47)
Thymulin modulates cytokine release by peripheral blood mononuclear cells: a comparison between healthy volunteers and patients with systemic lupus erythematosus. (1993) (47)
Warfarin and azathioprine: a drug interaction does exist. (1993) (47)
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis. (1989) (47)
HLA antigens and Bf allotypes in SLE: evidence for the association being with specific haplotypes. (1982) (47)
Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies. (1989) (47)
The Prosser-White oration 1983. Connective tissue disease and the skin. (1984) (46)
Antiphospholipid syndrome. (1993) (46)
Autoantibodies in the sicca syndrome (primary Sjögren's syndrome). (1984) (46)
Endomyocardial complications of the Churg-Strauss syndrome. (1985) (46)
Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy. (2005) (45)
Left ventricular function in patients with ankylosing spondylitis and Reiter's disease. (1984) (45)
Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. (1992) (45)
Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease. (1991) (45)
Atherogenesis in rheumatology (2006) (45)
Hydralazine, antinuclear antibodies, and the lupus syndrome. (1982) (45)
Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. (2005) (44)
Value of IgA anticardiolipin and anti-β2-glycoprotein I antibody testing in patients with pregnancy morbidity (2003) (44)
Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment (2001) (44)
Rheumatic disease in Jamaica. (1979) (43)
Association of antiphosphatidylserine/prothrombin autoantibodies with HLA class II genes. (2000) (43)
Antiphospholipid syndrome: linking many specialties. (1989) (43)
Pregnancy and lupus: prognostic indicators and response to treatment. (1988) (43)
Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant". (1984) (43)
Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus (2003) (42)
Autoantibodies in lupus and its variants: experience in 1000 patients. (1984) (42)
Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block. (2001) (42)
Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance (2003) (42)
Clinical and immunologic features of livedo reticularis in lupus: a case-control study. (1989) (42)
Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. (1999) (42)
Outcome of pregnancy in systemic lupus erythematosus. (1977) (42)
Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis. (1994) (41)
Character of anti-DNA antibodies in systemic lupus erythematosus. (1971) (41)
Systemic lupus erythematosus, antiphospholipid antibodies, chorea, and oral contraceptives. (1986) (41)
Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome. (1999) (40)
Systemic lupus erythematosus in 50 year olds. (1992) (40)
Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the "lupus anticoagulant" in systemic lupus erythematosus. (1989) (40)
Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. (2004) (40)
Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome. (1998) (39)
HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. (1992) (39)
Immunoglobulin A and polymeric IgA rheumatoid factors in systemic sicca syndrome: partial characterization. (1982) (38)
Headache and memory loss: rapid response to heparin inthe antiphospholipid syndrome (2001) (38)
Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus. (2005) (38)
The hepatic complications of the antiphospholipid antibodies. (1991) (37)
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures (2004) (37)
Criteria for Classification of S.L.E (1973) (37)
Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. (2004) (37)
Radioimmunoassay profile of antiglobulins in connective tissue diseases: elevated level of IgA antiglobulin in systemic sicca syndrome. (1981) (37)
Anti-C 1 q antibodies in nephritis : correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus (2005) (37)
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis. (1989) (37)
Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome. (1998) (36)
Antiphospholipid antibodies: an elderly statesman Dons new garments. (1987) (36)
Anti-mitochondrial type M5 and anti-cardiolipin antibodies in autoimmune disorders: studies on their association and cross-reactivity. (1987) (36)
Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus. (1991) (36)
Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. (1992) (36)
Congenital heart block and familial connective tissue disease. (1983) (36)
Sex hormones in male patients with systemic lupus erythematosus: a comparison with other disease groups. (1983) (36)
Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative (2007) (36)
Hughes (antiphospholipid) syndrome. Clinical features. (2001) (36)
Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis (2000) (35)
Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis. (1976) (35)
Thrombosis in Churg-Strauss syndrome. Beyond vasculitis? (1996) (35)
Coeliac disease and rheumatoid arthritis (1984) (34)
Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome (2001) (34)
Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. (1999) (34)
Update on therapy — thalidomide in the treatment of lupus (2001) (34)
Increase in the heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al. (2001) (34)
Antiphospholipid antibodies and chorea. (1988) (34)
Antiphospholipid syndrome and renal artery stenosis. (2000) (33)
Anticardiolipin antibody testing: the need for standardization. (1987) (33)
Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome—a report of two cases (1992) (33)
Lupus nephritis: the significance of serological tests at the time of biopsy. (1991) (33)
Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. (1992) (33)
Lupus pregnancy: is heparin a risk factor for osteoporosis? (2001) (33)
Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies. (1987) (33)
Treatment of systemic lupus erythematosus. (2001) (33)
Transient global amnesia and antiphospholipid antibodies. (1989) (33)
Thymulin and its role in immunomodulation. (1992) (32)
Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance (2005) (32)
Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome. (1993) (32)
Survival in systemic lupus erythematosus. (1988) (32)
The splenic extraction ratio of antibody-coated erythrocytes and its response to plasma exchange and pulse methylprednisolone. (1985) (32)
Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. (2000) (31)
Anti-cardiolipin antibodies and the lupus anticoagulant. (1986) (31)
Sjögren's Syndrome (1972) (31)
Anti-endothelial cell antibodies in retinal vasculitis. (1992) (31)
Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide (1982) (31)
Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I. (2003) (31)
A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus. (1988) (31)
Lessons from the "Euro-Lupus Cohort". (2002) (31)
The C1q binding assay in systemic lupus erythematosus: discordance with disease activity. (1980) (31)
Familial amyloidosis of Ostertag. (1982) (31)
Thin‐layer chromatography immunostaining in detecting anti‐phospholipid antibodies in seronegative anti‐phospholipid syndrome (2012) (30)
Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus (1992) (30)
Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus. (1977) (30)
Prevalence and clinical significance of subungual splinter haemorrhages in patients with the antiphospholipid syndrome. (1995) (30)
Association of HLA-DM polymorphism with the production of antiphospholipid antibodies (2004) (30)
Pulmonary artery aneurysms in Behçet's disease. (1985) (30)
Migraine in Hughes syndrome--heparin as a therapeutic trial? (2001) (29)
Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease. (1989) (29)
Strain differences in binding properties of estrogen receptors in immature and adult BALB/c and MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus. (2000) (29)
Hughes syndrome crosses boundaries. (2002) (29)
Immunological findings in Kawasaki disease: an evaluation in a cohort of Italian children. (1997) (29)
Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant? (2000) (28)
Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis. (1977) (28)
Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies. (2002) (28)
Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus (2001) (28)
Clinical improvement in antiphospholipid syndrome after rituximab therapy. (2008) (28)
Autoantibodies in systemic lupus erythematosus and urticarial vasculitis. (1995) (28)
Treatment of pregnancy loss in Hughes syndrome: a critical update. (2002) (28)
Systemic lupus erythematosus evolving into systemic vasculitis: a report of five cases. (1993) (28)
Allergic disorders in systemic vasculitis: a case-controlled study. (1994) (28)
Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus. (1994) (27)
Fcγ Receptor IIA H/R131 Polymorphism in Patients with Antiphospholipid Antibodies (1998) (27)
Aortic arch syndrome associated with anticardiolipin antibodies and the lupus anticoagulant: comment on Ferrante paper. (1985) (27)
Remission from polymyositis after total body irradiation. (1982) (27)
Arterial occlusion causing large bowel infarction — a reflection of clotting diathesis in SLE (2005) (27)
Myocardial infarction in systemic lupus erythematosus and "lupus-like" disease. (1986) (27)
Antiendothelial cell antibodies. (1989) (27)
Systemic lupus erythematosus: treatment and prognosis. (1979) (27)
Sjögren's syndrome presenting as a severe sensory neuropathy including involvement of the trigeminal nerve. (1984) (27)
The Budd-Chiari syndrome. Possible pathogenetic role of anti-phospholipid antibodies. (1986) (26)
Antiphospholipid (Hughes) Syndrome (2004) (26)
The Antiphospholipid Syndrome (1996) (26)
Heparin and osteoporosis during pregnancy: 2002 update (2002) (26)
The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies. (1989) (26)
Hughes syndrome (the antiphospholipid syndrome): 25 years old (2008) (26)
Theory, targets and therapy in systemic lupus erythematosus (2005) (26)
Antiphospholipid antibody testing: which are most useful for diagnosis? (2006) (26)
Portal and pulmonary hypertension in a case of systematic lupus erythematosus: possible relationship with a clotting abnormality. (1984) (26)
Evidence for sexual dimorphism of estrogen receptors in hypothalamus and thymus of neonatal and immature Wistar rats. (1999) (26)
Renal infarction associated with anti-phospholipid antibodies in systemic lupus erythematosus and "lupus-like" disease. (1988) (25)
Negative anticardiolipin antibodies and vascular complications in Behçet's syndrome. (1985) (25)
Intravenous immunoglobulin in the treatment of refractory adult Still's disease. (1999) (25)
Systemic lupus erythematosus and lymphoma: association with antiphospholipid syndrome. (1991) (25)
Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity. (1999) (25)
Minocycline-induced arthritis. (1998) (25)
Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE (2004) (25)
The heterogeneity of serologic findings and predisposing host factors in drug-induced lupus erythematosus. (1981) (25)
Antibodies to native DNA in discoid lupus erythematosus (1974) (24)
What causes lupus (2009) (24)
Veno-occlusive disease in systemic lupus erythematosus: possible association with anticardiolipin antibodies? (1984) (24)
Early Doppler Studies in Lupus Pregnancy (1992) (24)
The SL autoantibody-antigen system: clinical and biochemical studies. (1986) (24)
Sarcoid dactylitis. (1983) (24)
Common IgA and IgM rheumatoid factor idiotypes in autoimmune diseases. (1985) (23)
Systemic lupus erythematosus and sickle-cell anaemia. (1976) (23)
Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies. (2006) (23)
Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. (1992) (23)
Systemic lupus erythematosus (2001) (23)
Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma. (1995) (23)
Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups. (1977) (23)
Total body irradiation and the course of polymyositis. (1985) (23)
Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease. (2000) (23)
Rheumatoid arthritis and pulmonary hypertension. A report of three cases. (1985) (23)
Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies (2004) (23)
Hughes syndrome/APS. 30 years on, what have we learnt? Opening talk at the 14th International Congress on antiphospholipid antibodies Rio de Janiero, October 2013 (2014) (22)
Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. (1998) (22)
Use of monoclonal antibodies to identify shared idiotypes on anticardiolipin and anti-DNA antibodies in human sera. (1987) (22)
Antithrombin III in systemic lupus erythematosus. (1984) (22)
Acute Synovial Rupture of the Knee—A Differential Diagnosis from Deep Vein Thrombosis (1970) (22)
Syndrome X and Hughes syndrome (2002) (22)
Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: maternal and fetal complications and their management. (2000) (22)
Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus (2006) (22)
Effects of β2‐glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions (2002) (21)
Hughes syndrome and Multiple sclerosis (2015) (21)
Management of retinal vein occlusion (1988) (21)
Psychosis and catatonia as a first presentation of antiphospholipid syndrome. (2009) (21)
Central nervous system lupus--diagnosis and treatment. (1980) (21)
Synovial fluid phospholipase A2s and inflammation. (1989) (21)
Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study (2006) (21)
Diagnosis of antiphospholipid syndrome (2005) (20)
Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity. (1986) (20)
Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. (2002) (20)
Correlation between beta2-glycoprotein I valine/leucine247 polymorphism and anti-beta2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome. (1999) (20)
Combined temporal arteriography and selective biopsy in suspected giant cell arteritis. (1980) (20)
Hughes syndrome (2007) (20)
Antibodies to DNA in childhood systemic lupus erythematosus. (1971) (20)
The antiphospholipid (Hughes') syndrome: changing the face of neurology. (2004) (20)
Estrogen and progesterone receptors in murine models of systemic lupus erythematosus. (2001) (20)
Splenic function in non-renal systemic lupus erythematosus. (1980) (19)
Antibodies to Endothelial Cells and Vascular Damage (1993) (19)
Infliximab in patients with systemic vasculitis that is difficult to treat: poor outcome and significant adverse effects (2006) (19)
IL-2, IL-6 and TNF levels in primary antiphospholipid syndrome. (1992) (19)
Distal aortitis complicating Reiter's syndrome. (1984) (19)
Measurement of antibody to poly (adenosine diphosphate-ribose): its diagnostic value in systemic lupus erythematosus. (1984) (19)
Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis. (2008) (19)
Systemic lupus erythematosus. (1988) (18)
The Antiphospholipid Syndrome and ‘Multiple Sclerosis’ (1999) (18)
Concurrent systemic lupus erythematosus and salmonellosis. (1981) (18)
Coxsackie B infection and arthritis. (1983) (18)
Lymphocytotoxic antibodies in systemic lupus erythematosus: evidence for reactivity with i antigen. (1978) (18)
Dermatomyositis in HIV infection. (1988) (18)
Absence of antibodies to cardiolipin in patients with Huntington's chorea, Sydenhams chorea and acute rheumatic fever. (1988) (18)
Kinetics of heat damaged autologous red blood cells. Mechanism of clearance from blood. (2009) (18)
Malignant lymphoma in systemic rheumatic diseases. A report of five cases. (1991) (18)
Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data. (1993) (18)
Frequency of anti-DNA antibodies in SLE. RA and other diseases. Experience wiht the ammonium sulphate precipitation technique. (1975) (18)
Antiphospholipid antibodies in homozygous sickle cell disease. (1992) (17)
Evaluation of heat-damaged and IgG-coated red cells for testing reticuloendothelial function. (1982) (17)
Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS) (1993) (17)
Treatment of the antiphospholipid syndrome in pregnancy. (1998) (17)
Wegener's granulomatosis: onset during puerperium. (1984) (17)
Recurrent otitis media and pulmonary infiltrates as presenting features in Wegener's granulomatosis. (1988) (17)
Bony ankylosis in gout. (1968) (17)
Polymyositis-dermatomyositis: a clinical review. (1989) (17)
Therapeutic advances in systemic lupus erythematosus. (1998) (17)
Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies. (1990) (17)
Hughes syndrome (the antiphospholipid syndrome): a disease of our time (2011) (17)
Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis. (2001) (17)
A comparative trial of a controlled-release formulation of ketoprofen ('Oruvail') and a conventional capsule formulation of ketoprofen ('Orudis') in patients with osteoarthritis of the hip. (1984) (17)
ÆTIOLOGY OF JAMAICAN NEUROPATHY (1975) (16)
Streptococci and reactive arthritis. (1982) (16)
Hairy-cell leukaemia with polyarteritis nodosa. (1979) (16)
6 Antiphospholipid syndrome in SLE (1998) (16)
Measurement of splenic function in humans using heat damaged autologous red blood cells. (2009) (16)
Serum C-reactive protein in primary Sjögren's syndrome. (1983) (16)
Systemic inflammatory complications following jejuno-ileal bypass. (1982) (16)
Off the Beaten Track: A Clinician’s View (2000) (16)
Intracerebral arterial stenosis with neurological events associated with antiphospholipid syndrome. (2005) (15)
Antiphospholipid syndrome, migraine and stroke (2010) (15)
Therapy of systemic lupus erythematosus: new agents and new evidence (2000) (15)
Rituximab in lupus and beyond: the state of the art (2009) (15)
Reticulum cell sarcoma in azathioprine-treated systemic lupus erythematosus. (1979) (15)
Coxsackie B infection and arthritis (1983) (15)
IgG2 restriction of anti-beta2-glycoprotein I as the basis for the association between IgG2 anticardiolipin antibodies and thrombosis in the antiphospholipid syndrome: comment on the article by Sammaritano et al. (1998) (15)
‘Seronegative antiphospholipid syndrome’: an update (2019) (15)
The comparative blood clearance kinetics of modified radiolabelled erythrocytes. (1984) (15)
The progressive systemic sclerosis/systemic lupus overlap: an unusual clinical progression. (1991) (15)
Prevalence & clinical associations of anticardiolipin antibodies in patients with systemic lupus erythematosus in India. (1990) (15)
Prospective analysis of antiribonucleoprotein antibodies in systemic lupus erythematosus. (1977) (14)
Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome. (1982) (14)
SYSTEMIC LUPUS ERYTHEMATOSUS AND RELATED SYNDROMES (1992) (14)
Pulmonary hypertension and chronic cutaneous lupus erythematosus: association with the lupus anticoagulant. (1985) (14)
Systemic Lupus Erythematosus in Males: Analysis of Clinical and Laboratory Features (1992) (14)
Impaired estrogen priming of progesterone receptors in uterus of MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus (SLE). (2000) (14)
Hypotensive agents, beta-blockers, and drug-induced lupus. (1982) (14)
Distribution of Two Common Idiotypes of Anticardiolipin Antibodies in Sera of Patients with Primary Antiphospholipid Syndrome, Systemic Lupus Erythematosus and Monoclonal Gammopathies (1992) (14)
Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria? (2017) (14)
Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy. (2000) (14)
Diflunisal in the treatment of osteoarthrosis: a double-blind study comparing diflunisal with ibuprofen. (1978) (14)
Periorbital oedema in systemic lupus erythematosus. (2003) (14)
Antimalarial therapy in SLE. (1982) (14)
The ANCA test: its clinical relevance. (1990) (13)
Hypertension and the antiphospholipid antibodies. (1993) (13)
Studies of a popliteal synovial fistula. (1972) (13)
Complement factor 2 deficiency: a clinical and serological family study. (1992) (13)
Genetics of systemic lupus erythematosus. (1983) (13)
Systemic lupus erythematosus, pulmonary hypertension and adult respiratory distress syndrome (ARDS). (1988) (13)
[Neuropsychiatric manifestations in patients with systemic lupus erythematosus]. (1978) (13)
A normal ECG at birth does not exclude significant congenital cardiac conduction disease associated with maternal anti-Ro antibodies. (2001) (13)
CLINICAL MEASUREMENT OF SERUM C‐REACTIVE PROTEIN IN THE MONITORING AND DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY DISEASES AND TISSUE NECROSIS AND IN THE RECOGNITION AND MANAGEMENT OF INTERCURRENT INFECTION (1982) (13)
Effects of oestradiol and the oestrogen antagonist Ici 182,780 on the delayed type hypersensitivity (DTH) index and on serum levels of IgM and IgG in ovariectomised Balb/C and MRL/Mp-Lpr/Lpr mice, a model of systemic lupus erythematosus (SLE). (2001) (13)
Lupus patients are protected from cancer (2001) (13)
'Overlap' syndromes. (1990) (13)
Hypertrophic cardiomyopathy in systemic lupus erythematosus and "lupus-like" disease. Chance association? A report of 2 cases. (1992) (13)
Most anticardiolipin antibodies in mixed connective tissue disease are beta2-glycoprotein independent. (1998) (13)
Antiphospholipid antibodies and risk for recurrent vascular events. (2004) (13)
RECENT DEVELOPMENTS IN DRUG‐ASSOCIATED SYSTEMIC LUPUS ERYTHEMATOSUS (1987) (12)
Acute polyradiculoneuropathy complicating systemic lupus erythematosus. (1986) (12)
Sacro-iliac joint scanning with technetium-99 diphosphonate. (1979) (12)
SLE and pregnancy. (1988) (12)
ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS (1988) (12)
Antiphospholipid syndrome in SLE. (1998) (12)
Hypospray treatment of tennis elbow. (1969) (12)
Musculoskeletal manifestations of the antiphospholipid syndrome (2016) (12)
The eradication of congenital heart block (2004) (12)
Sulphasalazine and regression of rheumatoid nodules. (1987) (12)
Sulphamethoxazole-trimethoprim in the treatment of limited paranasal Wegener's granulomatosis. (2002) (12)
Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosis (2006) (11)
Chronic sarcoid arthritis. (1976) (11)
Is it lupus? The St. Thomas' Hospital "alternative" criteria. (1998) (11)
An evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of arterial thrombosis in patients with the antiphospholipid syndrome. (2000) (11)
Antiphospholipid antibodies--middle aged but robust. (1994) (11)
Sjögren's syndrome and fibrosing alveolitis complicated by pulmonary lymphoma. (1987) (11)
Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome (2003) (11)
Pulmonary hypertension in Sjögren's syndrome. (1988) (11)
Lymphocytotoxic antibodies in systemic lupus erythematosus: their clinical significance. (1979) (11)
Salicylate hepatotoxicity in systemic lupus erythematosus: a common occurrence? (1978) (10)
The problems of using NSAIDs in the elderly. (1991) (10)
Third International Antiphospholipid Conference: barbecues, rum punches, and kaps (1988) (10)
Advances in antiphospholipid (Hughes') syndrome. (1998) (10)
Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patients. (2001) (10)
An unusual cause of arthritis. (1983) (10)
Cardiovascular disease in systemic lupus erythematosus: has the time for action come? (2005) (10)
Effects of Oestradiol and the Oestrogen Antagonist lei 182,780 on the Delayed Type Hypersensitivity (DTH) Index and on Serum Levels of lgM and lgG in Ovariectomised Balb/C and MRL/Mp-Lpr/Lpr Mice, a Model of Systemic Lupus Erythematosus (SLE) (2001) (10)
Lupus: The Fifth Anniversary (1996) (10)
Vasculitis, antiphospholipid antibodies, and renal artery stenosis (2005) (10)
Systemic lupus erythematosus - Reply (2001) (10)
Sneddon's syndrome (1989) (10)
Specificity of estrogen receptors in rat thymus. (1993) (10)
Assessment of activity in SLE: a clinical and serological study. (1975) (10)
Possible mechanisms of action of the antiphospholipid binding antibodies. (1989) (10)
Aortic root thrombus causing stroke in a patient with systemic lupus erythematosus. (1994) (10)
Multiple sclerosis and the antiphospholipid (Hughes) syndrome: a common differential diagnosis? (2004) (10)
The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: a controlled study (2008) (9)
Immunoglobulin classes in skin basement membrane in systemic lupus erythematosus: clinical significance and comparison with classes of serum anti-DNA antibodies. (1979) (9)
Antiphospholipid antibodies, valvular heart disease and systemic lupus erythematosus. (1989) (9)
Immunology, lupus and atheroma (2000) (9)
Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera. (1980) (9)
Antiendothelial cell antibodies in chronic urticaria. (1995) (9)
Subacute cutaneous lupus erythematosus—the annular variant. A histological and ultrastructural study of five cases (1991) (9)
Immunological studies in 'primary' idiopathic pulmonary hypertension. (1984) (9)
The pathophysiology of anti-phospholipid antibodies. (1989) (9)
Heparin, antiphospholipid antibodies and the brain (2012) (9)
Genetics of antiendothelial cell antibodies in systemic lupus erythematosus: the role of HLA-DP alleles. (1992) (8)
Does SLE flare during pregnancy? (1998) (8)
Oral contraceptive therapy and systemic lupus erythematosus. (1978) (8)
An immune mechanism in thrombosis. (1988) (8)
Successful pregnancy following suppression of anticardiolipin antibody and lupus anticoagulant with azathioprine in systemic lupus erythematosus. (1986) (8)
Cryoglobulins, anticardiolipin antibodies and livedo reticularis. (1992) (8)
Phospholipid Autoantibodies — Cardiolipin (1996) (8)
Renal microinfarction in Behçet's disease. (2003) (8)
Assay of protein S in systemic lupus erythematosus (1995) (8)
Chronic active hepatitis in a patient presenting with clinical and serological evidence of SLE. (1979) (8)
"Listen to the patient"--anticoagulation is critical in the antiphospholipid (Hughes) syndrome. (2003) (8)
Mycophenolate mofetil: A potential treatment for reducing proteinuria associated with membranous lupus nephritis. (2003) (8)
[Anti-endothelial cell antibodies in systemic lupus erythematosus: association with vascular and renal lesions]. (1992) (7)
Thrombocytopenia in the antiphospholipid syndrome. (1997) (7)
Circulating oxidized LDL forms complexes with β2-glycoprotein I Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200329-JLR200 (2003) (7)
Vascular disease, thrombosis, and recurrent abortion. (1988) (7)
Diagnosis of sarcoidosis by labial gland biopsy. (1972) (7)
A comparison of two formulations of indomethacin ('Flexin Continus' tablets and 'Indocid' capsules) in the treatment of rheumatoid arthritis. (1990) (7)
Heart Disease, Pregnancy and Systemic Autoimmune Diseases (2007) (7)
Practical management of pregnancy in systemic lupus erythematosus (1993) (7)
Enhancement of cryoprecipitation from hypotonic serum: a comparative study in normals and in patients with connective tissue diseases. (1983) (7)
Genetic Susceptibility to Systemic Lupus-Erythematosus (1984) (7)
Systemic lupus erythematosus complicated by tricuspid stenosis and regurgitation: successful treatment by valve transplantation. (1992) (7)
Antiphospholipid antibodies: a review. (1984) (7)
Sjøgren's Syndrome (1973) (7)
Prevalence of hypertension in 600 patients with antiphospholipid syndrome. (2003) (7)
The treatment of SLE: the case of conservative management. (1982) (7)
Proceedings: A serial study of eosinophilia and raised IgE antibodies during gold therapy. (1975) (7)
EVALUATION OF ANTI‐NUCLEAR ANTIBODY TESTS: A REPORT ON THE WORKSHOP OF THE AUSTRALIAN RHEUMATISM ASSOCIATION OCTOBER 1980 (1981) (6)
Is there a role for phospholipases in the anti-cardiolipin syndrome? (1988) (6)
Double-stranded RNA antibodies in systemic lupus erythematosus. (1975) (6)
Neurology and the lupus anticoagulant. (1985) (6)
Speculations on APS in the coming millennium. (2000) (6)
Hughes syndrome (antiphospholipid syndrome) and myocardial infarction (2010) (6)
P 160 Antibodies to endothelial cells in patients with Behçet's disease (1993) (6)
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions. (2002) (6)
Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele. (1986) (6)
Polymyositis complicating D-penicillamine treatment. (1991) (6)
Methotrexate treatment of Felty's syndrome. (1990) (6)
Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvement. (1995) (6)
Thrombocytopenia in a case of systemic lupus erythematosus: repeated administration of 'pulse' methyl prednisolone. (1984) (6)
The association of pure red cell aplasia with the antiphospholipid syndrome (2001) (6)
European Working Party on Systemic Lupus Erythematosus: a 10 year report (2001) (6)
Anticardiolipin antibodies and lupus anticoagulant. (1987) (6)
Anti-PL4 antibody in SLE. (1998) (6)
Platelet Sensitivity to Prostacyclin and Prostaglandin E1 in Raynalid's Syndrome (1982) (5)
Lupus and the nervous system (2003) (5)
Prostacyclin in systemic lupus and anticardiolipin syndrome. (1987) (5)
Systemic lupus erythematosus--some aspects of management. (1981) (5)
Use of anti-idiotypic antibodies to demonstrate rheumatoid factor producing bone marrow cells in essential mixed cryoglobulinaemia. (1984) (5)
Sjögren's syndrome. (1972) (5)
Neurological manifestations of anti-phospholipid (Hughes) syndrome. (2004) (5)
Vocal cord paralysis in systemic lupus erythematosus complicated by pulmonary hypertension. (1985) (5)
Systemic Lupus Erythematosus and Related Disorders (1988) (5)
[Orthopedic manifestations of the antiphospholipid syndrome]. (2007) (5)
Hepatomegaly as a rare presentation of Churg-Strauss syndrome. (2005) (5)
New therapies for systemic lupus erythematosus: has the future arrived? (2006) (5)
Clinical significance of anti-beta 2-glycoprotein I antibodies. (1996) (5)
Perspectives on the changing face of lupus mortality. (2004) (5)
Rheumatoid arthritis--an overview. (1982) (5)
Pulmonary involvement in angioimmunoblastic lymphadenopathy following autoimmune disease. (1983) (5)
Circulating C1q binding immune complexes in relatives of patients with systemic lupus erythematosus. (1983) (5)
Double blind, crossover, randomised trial comparing low molecular weight heparin versus placebo in the treatment of chronic headache (2003) (5)
Multiple small-vessel occlusions in systemic lupus erythematosus. (1989) (5)
Lymphosarcomatous arthropathy. (1973) (5)
Cerebral embolism complicating Libman-Sacks endocarditis--full recovery using recombinant tissue plasminogen activator. (2002) (5)
Current understanding of systemic lupus erythematosus (1984) (4)
The clinical aspects of the antiphospholipid syndrome (2004) (4)
P 162 Anti-endothelial cell antibodies and endothelial cell dysfunction in Behçet's disease (1993) (4)
The effect of a protein meal on three fluid-phase assays for circulating immune complexes. (1981) (4)
Sweat gland function in Sjögren's syndrome. (1986) (4)
Jarisch-Herxheimer reaction and syphilitic aortitis. (1968) (4)
Markers of vascular damage in lupus pregnancy. (1997) (4)
Yersinia arthritis: demonstration of occult enteritis by 111indium leucocyte scanning. (1984) (4)
The syndrome of thrombosis, abortion, and neurological disease. (1984) (4)
Anticentromere antibody and pulmonary hypertension. (1984) (4)
Circulating human leucocyte elastase in rheumatoid arthritis (2004) (4)
Antiphospholipid antibodies and valve disease in patients with systemic lupus erythematosus. (1993) (4)
Anti-DNA antibodies in discoid lupus erythematosus. Follow-up study. (1977) (4)
Mixed connective tissue disease with digital gangrene. (1975) (4)
Intractable Polymyositis: Prolonged Remission Induced by Total Body Irradiation (1985) (4)
Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE) (1997) (4)
Rheumatoid arthritis: current concepts. (1982) (4)
Plasma exchange (plasmapheresis). (1980) (4)
Antiphospholipid antibodies: which and when? (1990) (4)
Antiphospholipid antibodies, lupus-like disease and the “primary” antiphospholipid syndrome (1989) (3)
The Big 3 (2018) (3)
Psychiatric disorders in patients with systemic lupus erythematosus: lack of association with antiphospholipid antibodies. (1993) (3)
Anticardiolipin antibodies, livedo reticularis, and cerebrovascular accidents in SLE. (1988) (3)
Atypical lupus with special reference to ANA negative lupus and lupus subsets. (1985) (3)
Prevalence of headache and relationship with the presence of antiphospholipid antibodies in systemic lupus erythematosus (2000) (3)
Lupus: The Facts (2000) (3)
Seronegative antiphospholipid syndrome. Author's reply (2004) (3)
Serum antibodies from patients with neuropsychiatric systemic lupus erythematosus cause activation and damage to an in vitro blood-brain barrier model (2000) (3)
Antiphospholipid antibodies and shrinking lungs in SLE. (1992) (3)
Antiphospholipid Syndrome and Atherosclerosis (2001) (3)
Intravenous methylprednisolone in the treatment of systemic lupus erythematosus. (1984) (3)
The treatment of lupus nephritis (2005) (3)
A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. (1984) (3)
Methotrexate in systemic lupus erythematosus. (1997) (3)
Influence of rifampicin on hydroxychloroquine. (1995) (3)
Vascular disease and thrombosis: relationship to the antiphospholipid antibodies. (1992) (3)
Antiphospholipid antibodies in a Brazilian population with systemic lupus erythematosus. (1989) (3)
Lack of Specific Binding of Anticardiolipin Antibodies to Intact Platelets (1992) (3)
Hypocomplementaemic urticarial vasculitis, angio-oedema and 'lupus-like' disease: association with C4B null allele. (1987) (3)
Hughes syndrome (antiphospholipid syndrome) and the nervous system (2018) (3)
Hughes syndrome--the syndrome behind the name (otherwise known as antiphospholipid syndrome). (1999) (3)
Anti-Ro and Lymphopenia in SLE (1993) (3)
Neurological manifestations of antiphospholipid ( Hughes ) syndrome (2004) (3)
Prolactin, the immune response and lupus. (1999) (3)
Lupus around the world (2015) (3)
Clinical significance of anti-β2-glycoprotein I antibodies (1996) (3)
Significance of CRP elevation in SLE. (1983) (2)
Hughes Syndrome: Highways and Byways (2013) (2)
The prevalence of an abnormal ankle-brachial index in primary Antiphospholipid Syndrome. (2003) (2)
Preclinical atherosclerotic phenotype in patients with primary antiphospholipid syndrome. (2006) (2)
Patterns of Pulmonary Functional Abnormality in Systemic Lupus Erythematosus (1976) (2)
Immunology and rheumatology. (1982) (2)
Ptosis in systemic lupus erythematosus (1982) (2)
Rituximab: an update (2007) (2)
Antiphospholipid syndrome. (1999) (2)
DNA antibodies in the diagnosis and management of SLE. (1971) (2)
Anti-DNA activity in systemic lupus erythematosus. (2011) (2)
Outcome in patients with anticardiolipin antibodies: A prospective 4 years follow-up (2000) (2)
Anticardiolipin antibody. (1989) (2)
Hughes syndrome: a disease of our time (2009) (2)
The Role of Antiphospholipid Syndrome in Critical Illness (2000) (2)
Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus. (1981) (2)
The anticardiolipin syndrome. (1985) (2)
Pancytopenia in ANCA associated vasculitis: response to immunosuppressive therapy. (2003) (2)
Proceedings: Circulating complexes and disease activity in SLE. (1975) (2)
Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria? (2016) (2)
Arthritis and the Connective Tissue Diseases (1978) (2)
The effect of anti-Ro antibody of the fetus in the absence of overt congenital complete heart (2002) (1)
Revisiting antiphospholipid antibodies (2004) (1)
Hughes Syndrome: A Patient’s Guide (2001) (1)
Pregnancy and Fetal Loss (2016) (1)
What is lupus (2012) (1)
Class III HLA Genes and Systemic Lupus Erythematosus (1986) (1)
Hughes syndrome (the antiphospholipid syndrome): 25 years old (2008) (1)
Problems in the Rheumatic Diseases (1988) (1)
Protein S, C4b-binding protein (C4BP) and beta 2-glycoprotein I (??2-GPI) binding interaction: Inhibition by human monoclonal anticardiolipin antibody (Mo-aCL) (1995) (1)
The Endovascular Compartment (1998) (1)
The Use of the Hypospray in the Treatment of Minor Orthopædic Conditions [Abstract] (1969) (1)
Renal artery stenosis in hypertensive patients with antiphosphotipid syndrome: The effects of anticoagulation. (2003) (1)
Immunoglobulin classes inskin basement membrane insystemic lupus erythematosus: clinical significance andcomparison withclasses ofserum anti-DNA antibodies (1979) (1)
Laboratory investigations in the early diagnosis of the rheumatic diseases. (1978) (1)
Dermatomyositis developing in a Duchenne muscular dystrophy carrier. (2004) (1)
Antibodies to beta2-glycoprotein I (1998) (1)
Understanding Hughes Syndrome: Case Studies for Patients (2008) (1)
Drug and Environmental Lupus Syndromes (1994) (1)
Sarcoidosis presenting as subacute polydactylitis. (1981) (1)
The Spinal Cord and “Multiple Sclerosis” (2016) (1)
SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DISEASES SUBSETS IN A COHORT OF 1000 PATIENTS (EURO-LUPUS PROJECT) (1992) (1)
Juvenile rheumatoid arthritis in two siblings: co-existence with polyarteritis nodosa in one parent. (1984) (1)
Therapeutic choices for rheumatic disorders. (1988) (1)
A comparison of two formulations of indomethacin ('Flexin Continus' tablets and 'Indocid' capsules) in the treatment of osteoarthritis. (1990) (1)
Thromboprophylaxis with low molecular weight heparin during pregnancy (1994) (1)
Immunologic testing in stroke patients [2] (1995) (1)
Rheumatic disease inJamaica (1979) (1)
Problems in the Rheumatic Diseases: Lessons from Patients (1988) (1)
Antiphospholipid antibodies and cardiovascular disease (1993) (1)
The use of the hypospray in the treatment of minor orthopaedic conditions. (1969) (1)
Miscarriage and heart attack (2011) (1)
Seronegative antiphospholipid syndrome - Reply (2004) (1)
Rheumatoid factors in Ro (SSA) positive and Ro (SSA) negative rheumatoid arthritis patients (2004) (1)
MALToma and lupus (2005) (1)
Cerebrovascular disease in the Hughes/antiphospholipid syndrome (APS) (2000) (1)
Immunopathogenesis of SLE & drug targets (2012) (1)
Materno-fetal transmission of autoimmune disease. (2003) (1)
Livedo reticularis and lupus erythematosus clinical and immunological associations (1986) (1)
Lecture Notes on Rheumatology (1986) (1)
[Neurological manifestations of the antiphospholipid syndrome]. (2005) (1)
Hughes Syndrome: A Short History of Antiphospholipid Syndrome (1999) (1)
Late Pregnancy Tragedy (2009) (0)
Hypertension in primary antiphospholipid syndrome. (2003) (0)
Recent advances in lupus erythematosus. (1978) (0)
195 Anticardiolipin antibody binding to platelet membranes: A possible mechanism for thrombosis in autoimmune disorders (1988) (0)
Other drugs and treatments in lupus (2009) (0)
Complement factor 2 deficiency: serological family study (2004) (0)
New Directions for Research in Systemic Lupus Erythematosus (1979) (0)
The “Catastrophic” Antiphospholipid Syndrome (2016) (0)
Further reading and websites (2018) (0)
Antiphospholipid antibodies: ariskfactor for occlusive ocular vascular disease insystemic lupus erythematosus andthe'primary' antiphospholipid (1989) (0)
Links to Other Diseases (2012) (0)
Diagnosis I: Blood Tests (2014) (0)
Antibodies against phospholipids — A major risk factor for thrombosis (1988) (0)
Why don't lupus patients catch cold? (2008) (0)
Plaquenil® and antimalarials (2009) (0)
THE FREQUENCY and CLINICAL SIGNIFICANCE OF ANTIBODIES TO RIBONUCLEO‐PROTEIN (RNP) and OF SJOGREN'S SYNDROME IN PATIENTS WITH CONNECTIVE TISSUE DISEASES (1978) (0)
Detection andimportance ofanticardiolipin antibodies (1993) (0)
Comment on Isenberg article (Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus) (1984) (0)
Lupus: An introduction (2012) (0)
Modern Topics in Rheumatology (1977) (0)
Tendons and joints (2012) (0)
Sjogren's syndrome andfibrosing alveolitis complicated bypulmonary lymphoma (1987) (0)
Systemic (disseminated) lupus erythematosus. (1980) (0)
Nature of pulmonary functional disturbances in SLE (1976) (0)
[Sneddon syndrome and antiphospholipid antibodies]. (1988) (0)
Heart and Stroke: The Impact of Hughes Syndrome(Antiphospholipid Syndrome) (2016) (0)
Lupus and the world around us (2009) (0)
Aortic occlusion insystemic lupuserythematosus associated withantiphospholipid antibodies (1987) (0)
Hughes Syndrome: Pregnancy and Fertility (2012) (0)
Hughes’ Syndrome and Lupus (2016) (0)
Membranous lupus nephritis: An update. (2003) (0)
Memory Loss and “Alzheimers” (2016) (0)
What Blood Tests Do We Use (2016) (0)
Protein Z gene polymorphisms in systemic lupus erythematosus (2008) (0)
Neuropsychiatric manifestations in the antiphospholipid (Hughes) syndrome (2004) (0)
Association of antiphospholipid antibodies and neuropsychiatric involvement in patients with systemic lupus erythematosus (2000) (0)
Premature cardiovascular disease in SLE: A study from a tertiary referral centre. (2003) (0)
Renal biopsy findings in lupus patients with and without Antiphospholipid antibodies. (2002) (0)
Pregnancy and lupus (2009) (0)
Abstract 1316: Preclinical Atherosclerosis in Primary Antiphospholipid Syndrome: The Impact of Oxidative Properties of High Density Lipopoprotein (2007) (0)
LUPUS – 25 years old (2016) (0)
Useofanti-idiotypic antibodies todemonstrate rheumatoid factor producing bonemarrowcells in essential mixedcryoglobulinaemi a (1984) (0)
Systemic Lupus Erythematosus: Causative Factors and Treatment (1982) (0)
Captopril and drug-induced lupus (1982) (0)
Letter to the Editor (2003) (0)
RHEUMATIC DISEASES Leader The ANCA test : its clinical relevance (0)
Lupus: The First Two Years (1994) (0)
Proceedings: Measurement of DNA antibodies--a 3-year clinical survey. (1974) (0)
Conclusions: The World Map (2012) (0)
Biological therapies in lupus (2016) (0)
TheSLautoantibody-ant igen system: clinical andbiochemical studies* (1986) (0)
Treatment of Hughes syndrome (2009) (0)
Osteoporosis and lupus (2009) (0)
Plasma levels of TNF alpha are increased in patients with the antiphospholipid syndrome (2000) (0)
INCREASED RATE OF LUPUS FLARE DURING PREGNANCY AND THE PUERPERIUM : A PROSPECTIVE STUDY OF 78 PREGNANCIES (1996) (0)
Medical Disorders of Pregnancy (1977) (0)
Hughes Syndrome: The Clinical Features (2012) (0)
Antibodies to Extractable Nuclear Antigens — a Simple Method for Their Identification (1982) (0)
The world of lupus (2017) (0)
Sjögren’s Overlaps (2014) (0)
Comprar Hughes Syndrome. A Patient’s Guide 2nd Ed. | Graham Hughes | 9783319310282 | Springer (2016) (0)
Methotrexate treatment of Felth's syndrome (1990) (0)
Liver and Gastrointestinal Tract (2013) (0)
Duncan Gordon (2013) (0)
Length of gestation in systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS): Survival analysis of 282 pregnancies in 152 women. (2002) (0)
Diagnosis II: Other Tests (2014) (0)
Sjögren’s and Lymphoma (2014) (0)
Book Review: Cancer & Autoimmunity Eds Shoenfeld Y & Gershwin ME (2000) (0)
Understanding Hughes Syndrome (2009) (0)
Migraine and Stroke (2012) (0)
Rheumatoid arthritis. (1979) (0)
[Antineural antibodies in patients with systemic lupus erythematosus]. (1981) (0)
Proceedings: Antibodies to RNA in the connective tissue diseases. (1974) (0)
“Personality Disorder” in a 4-Year-Old …… (2009) (0)
The clinical picture (2009) (0)
Clinician's Manual on Lupus (2012) (0)
40 – THE CLINICAL ASPECTS OF THE ANTIPHOSPHOLIPID SYNDROME (2004) (0)
Antibodies to polynucleotides in SLE (1975) (0)
Heart and blood vessels (2012) (0)
Lupus in a nutshell (2009) (0)
Proceedings: Systemic lupus erythematosus and rheumatoid arthritis. (1976) (0)
Book Reviews: Dubois' Lupus Erythematosus, edited by D.J. Wallace and B.H. Hahn (1993) (0)
The Anti-Cardiolipin Assay (2020) (0)
Proceedings: Anti-DNA antibodies in discoid lupus erythematosus. (1974) (0)
A prospective analysis (0)
The complement system--a review. (1976) (0)
Demyelinating syndromes in autoimmune connective tissue diseases: Association with antiphospholipid antibodies. (2003) (0)
Pain in the Foot (“Toelitis”) (2009) (0)
Anti-Phospholipid Antibodies: A Personal History (2020) (0)
Mixed connective tissue disease (Sharpe’s syndrome) (2009) (0)
Lupus comes of age. (1992) (0)
Antiphospholipid antibodies in sickle cell disease. (1994) (0)
The London Lupus Centre, Book of Lupus: A Patients' Guide (2008) (0)
Lupus-related topics (2012) (0)
SLE in 21st Century (2016) (0)
[Diabetic cheirarthropathy simulating sclerodermia]. (1990) (0)
Anti-c1q in lupus nephritis: Strong correlation between titres and renal disease activity. (2003) (0)
Ear, nose, and throat symptoms in subacute Wegener's granulomatosis: Authors' reply (1989) (0)
Reticulum cell sarcoma inazathioprine-tre ated systemic lupus erythematosus (1979) (0)
Mixed connective tissue disease (and overlap syndromes) (2012) (0)
Antiprothrombin antibodies in infections and antiphospholipid syndrome (2000) (0)
Apolipoprotein(a) deposition in atherosclerotic coronary arteries of a patient with systemic lupus erythematosus: comment on the article by Romero et al - Reply (2000) (0)
Letter: Aetiology of Jamaican neuropathy. (1975) (0)
Systemic lupus erythematosus (2001) (0)
Hughes syndrome/APS (2017) (0)
Joints, Tendons, Muscles (2014) (0)
The MISSILE study: A randomised controlled trial of mycophenolate mofetil versus placebo on surrogate markers of atherosclerosis in systemic lupus erythematosus (2008) (0)
My Sister has Hughes Syndrome (2009) (0)
P 147 Negative anti-neutrophil cytoplasmic antibodies in patients with Behçet's disease (1993) (0)
Low frequency of IgA anticardiolipin antibody in patients with systemic lupus erythematosus (2000) (0)
Repeat real biopsy is a useful investigation in the management of lupus nephritis. (2003) (0)
Tests for Hughes Syndrome (2013) (0)
Antiphospholipid syndrome and Lupus (2018) (0)
Immunemediated mechanism forthrombosis: antiphospholipid antibody binding toplatelet membranes* (1988) (0)
[Systemic lupus erythematosus: new perspectives]. (1991) (0)
Contents, Vol. 24, 1985 (1985) (0)
W1408 Association of Autoimmune Connective Tissue Disorders in Patients With Gastrointestinal Neuromuscular Disorders (GINMD) (2010) (0)
Prospective analysis ofantiribonucleopr otein antibodies insystemic lupus erythematosus (1977) (0)
Bones and Joints (2012) (0)
A 47-year-old woman presenting with a 20-year history of SLE. (1989) (0)
Antiphospholipid antibodies and HLA associations in primary S jogren ' s syndrome (0)
Hughes Syndrome: The Causes – Genetics Versus Environment (2012) (0)
The role of antiaggregant and anticoagulant therapy in the treatment of headache in systemic lupus erythematosus (2000) (0)
Severe thrombocytopenia in an adult patient with mixed connective tissue disease. (1982) (0)
Hla Antigens and Antibody TO RO (SS-A) in SLE (1982) (0)
Treatment of vasculitis with cyclophosphamide. (1979) (0)
In Memoriam: Charles Christian, MD, 1926–2019 (2019) (0)
ELISA using Thrombofax is useful to verify antiphospholipid antibodies. (1990) (0)
[Disseminated lupus erythematosus: an analysis of organ involvement]. (1978) (0)
Subject Index Vol. 24, 1985 (1985) (0)
Anti-c1q autoantibodies as a predictor of lupus nephritis. (2003) (0)
The Schirmer test and drug allergy in rheumatoid arthritis. (1980) (0)
The rise and rise of lupus (2009) (0)
Autoantibodies inthesicca syndrome (primary Sjogren's syndrome) (1984) (0)
Correction of Previews 200100168381. Absence of conduction defects in the electrocardiograms of mothers with children with congenital complete heart block. Correction of title.) (2001) (0)
A double blind, placebo controlled trial of intravenous methylprednisolone (1988) (0)
Iconography : Manifestations osseuses du syndrome des antiphospholipides (2007) (0)
Neuropsychiatric lupus: Relevance of Antiphospholipid antibodies. (2002) (0)
Sulphasalazine andregressionofrheumatoid nodules (1987) (0)
Arteries and Veins (2013) (0)
Liver and Gut (2012) (0)
Mouth and Salivary Glands (2014) (0)
The Tests are Negative (2009) (0)
Antiprothrombin antibodies: Detection, immunological characteristics and clinical significance in patients with systemic lupus erythematosus. (2002) (0)
Sticky Blood: the Disease Is Common (2016) (0)
Hairy cell leukemia and arteritis. (1983) (0)
The Nervous System (2014) (0)
Kawasaki syndrome: the Florentine experience (1996) (0)
Anti-vimentin/cardiolipin antibodies in “seronegative” Antiphospholipid syndrome (2010) (0)
General treatment of lupus (2009) (0)
Rheumatology. (1991) (0)
A diagnostic andtherapeutic guide (1971) (0)
Main Clinical Features (2016) (0)
Complement fixation byanti-dsDNA antibodies in SLE:measurementbyradioimmunoassay and relationship withdisease activity (1986) (0)
Multiple microinfarcts in the Hughes/antiphospholipid syndrome (APS) (2000) (0)
94116566 Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE) (1995) (0)
Foreward. Inaccurately named antiphospholipid antibodies (aPL). (2014) (0)
Treatment of systemiclupus erythematosus (2001) (0)
Diagnosis and Classification (2019) (0)
Laryngeal dysfunction and rheumatoid arthritis. A case report. (1980) (0)
Immunological And Demographic Factors Associated With Lupus Nephritis (2002) (0)
Movement Disorders and Seizures (2012) (0)
Causes of Sjögrens (2014) (0)
Human Ro 60 gene structure, organization and sequence alterations in cutaneous lupus erythematosus. (2001) (0)
Mad Cow Disease (2009) (0)
Comparative Clearance Kinetics of Beat Damaged (Hdrc) and Antibody Coated Red Cells (Igrc) (1982) (0)
[Systemic lupus erythematosus. A new look]. (1985) (0)
Systemic Lupus Erythematosus, Antiphospholid Syndrome, Scleroderma, and Inflammatory Myopathies (2001) (0)
Headaches, Migraine and Fits (2016) (0)
A Defect of the Alternative Pathway of Complement in Sickle Cell Disease (1976) (0)
Multiple Oleomas Presenting as Dermatomyositis. (2015) (0)
Criteria for Classification of Systemic Lupus Erythematosus (1974) (0)
Foreword: Antimalarials in rheumatology (1996) (0)
Ear, Nose and Throat (2012) (0)
Immunotherapy of multiple sclerosis--current status and future perspectives. September 15, 1984, Zurich, Switzerland. Abstracts. (2004) (0)
Sjögren’s Syndrome in Clinical Practice (2014) (0)
Anticardiolipin antibodies and cardiovascular disease. (1996) (0)
Registrars' Forum: Summaries of Papers (2001) (0)
Spinal Cord (Including Multiple Sclerosis) and Peripheral Nerves (2012) (0)
Reassessing thestatusofantiphospholipid syndrome insystemic lupuserythematosus (1992) (0)
Clotting in Veins (2016) (0)
Lymphocyte antigens in systemic lupus erythematosus detected by heterologous rabbit antisera. (1979) (0)
Complement deficiency in systemic lupus erythematosus (2003) (0)
The Laboratory Investigation of Rheumatic and Connective Tissue Diseases (1985) (0)
[Role of platelet phospholipases in the antiphospholipid antibody syndrome]. (1988) (0)
Bladder, Vagina, Kidney (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Graham R. .v. Hughes?

Graham R. .v. Hughes is affiliated with the following schools:

Graham R. .v. Hughes's Academic­Influence.com Rankings

Why Is Graham R. .v. Hughes Influential?

Graham R. .v. Hughes's Published Works

Published Works

What Schools Are Affiliated With Graham R. .v. Hughes?

Graham R. .v. Hughes's AcademicInfluence.com Rankings